JOHNSON & JOHNSON Annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Johnson & Johnson quarterly/annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect history and growth rate from 2017 to 2023.
  • Johnson & Johnson Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending March 31, 2024 was $3.61B, a 71.6% decline year-over-year.
  • Johnson & Johnson annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2023 was $7.73B.
  • Johnson & Johnson annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2022 was -$360M, a 172% decline from 2021.
  • Johnson & Johnson annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2021 was $502M.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Annual (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $7.73B +$8.09B Jan 2, 2023 Dec 31, 2023 10-K 2024-02-16
2022 -$360M -$862M -172% Jan 3, 2022 Jan 1, 2023 10-K 2024-02-16
2021 $502M +$3.82B Jan 4, 2021 Jan 2, 2022 10-K 2024-02-16
2020 -$3.32B -$2.52B -314% Dec 30, 2019 Jan 3, 2021 10-K 2023-02-16
2019 -$802M -$1.09B -383% Dec 31, 2018 Dec 29, 2019 10-K 2022-02-17
2018 $283M +$1.43B Jan 1, 2018 Dec 30, 2018 10-K 2021-02-22
2017 -$1.15B Jan 2, 2017 Dec 31, 2017 10-K 2020-02-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.